1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oral Hypoglycemic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Liquid
        1.2.3 Capsule
        1.2.4 Tablet
    1.3 Market by Application
        1.3.1 Global Oral Hypoglycemic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Oral Hypoglycemic Agents Market Perspective (2017-2028)
    2.2 Oral Hypoglycemic Agents Growth Trends by Region
        2.2.1 Oral Hypoglycemic Agents Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Oral Hypoglycemic Agents Historic Market Size by Region (2017-2022)
        2.2.3 Oral Hypoglycemic Agents Forecasted Market Size by Region (2023-2028)
    2.3 Oral Hypoglycemic Agents Market Dynamics
        2.3.1 Oral Hypoglycemic Agents Industry Trends
        2.3.2 Oral Hypoglycemic Agents Market Drivers
        2.3.3 Oral Hypoglycemic Agents Market Challenges
        2.3.4 Oral Hypoglycemic Agents Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Oral Hypoglycemic Agents Players by Revenue
        3.1.1 Global Top Oral Hypoglycemic Agents Players by Revenue (2017-2022)
        3.1.2 Global Oral Hypoglycemic Agents Revenue Market Share by Players (2017-2022)
    3.2 Global Oral Hypoglycemic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Oral Hypoglycemic Agents Revenue
    3.4 Global Oral Hypoglycemic Agents Market Concentration Ratio
        3.4.1 Global Oral Hypoglycemic Agents Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oral Hypoglycemic Agents Revenue in 2021
    3.5 Oral Hypoglycemic Agents Key Players Head office and Area Served
    3.6 Key Players Oral Hypoglycemic Agents Product Solution and Service
    3.7 Date of Enter into Oral Hypoglycemic Agents Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Hypoglycemic Agents Breakdown Data by Type
    4.1 Global Oral Hypoglycemic Agents Historic Market Size by Type (2017-2022)
    4.2 Global Oral Hypoglycemic Agents Forecasted Market Size by Type (2023-2028)
5 Oral Hypoglycemic Agents Breakdown Data by Application
    5.1 Global Oral Hypoglycemic Agents Historic Market Size by Application (2017-2022)
    5.2 Global Oral Hypoglycemic Agents Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Oral Hypoglycemic Agents Market Size (2017-2028)
    6.2 North America Oral Hypoglycemic Agents Market Size by Type
        6.2.1 North America Oral Hypoglycemic Agents Market Size by Type (2017-2022)
        6.2.2 North America Oral Hypoglycemic Agents Market Size by Type (2023-2028)
        6.2.3 North America Oral Hypoglycemic Agents Market Share by Type (2017-2028)
    6.3 North America Oral Hypoglycemic Agents Market Size by Application
        6.3.1 North America Oral Hypoglycemic Agents Market Size by Application (2017-2022)
        6.3.2 North America Oral Hypoglycemic Agents Market Size by Application (2023-2028)
        6.3.3 North America Oral Hypoglycemic Agents Market Share by Application (2017-2028)
    6.4 North America Oral Hypoglycemic Agents Market Size by Country
        6.4.1 North America Oral Hypoglycemic Agents Market Size by Country (2017-2022)
        6.4.2 North America Oral Hypoglycemic Agents Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Oral Hypoglycemic Agents Market Size (2017-2028)
    7.2 Europe Oral Hypoglycemic Agents Market Size by Type
        7.2.1 Europe Oral Hypoglycemic Agents Market Size by Type (2017-2022)
        7.2.2 Europe Oral Hypoglycemic Agents Market Size by Type (2023-2028)
        7.2.3 Europe Oral Hypoglycemic Agents Market Share by Type (2017-2028)
    7.3 Europe Oral Hypoglycemic Agents Market Size by Application
        7.3.1 Europe Oral Hypoglycemic Agents Market Size by Application (2017-2022)
        7.3.2 Europe Oral Hypoglycemic Agents Market Size by Application (2023-2028)
        7.3.3 Europe Oral Hypoglycemic Agents Market Share by Application (2017-2028)
    7.4 Europe Oral Hypoglycemic Agents Market Size by Country
        7.4.1 Europe Oral Hypoglycemic Agents Market Size by Country (2017-2022)
        7.4.2 Europe Oral Hypoglycemic Agents Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Oral Hypoglycemic Agents Market Size (2017-2028)
    8.2 Asia-Pacific Oral Hypoglycemic Agents Market Size by Type
        8.2.1 Asia-Pacific Oral Hypoglycemic Agents Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Oral Hypoglycemic Agents Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Oral Hypoglycemic Agents Market Share by Type (2017-2028)
    8.3 Asia-Pacific Oral Hypoglycemic Agents Market Size by Application
        8.3.1 Asia-Pacific Oral Hypoglycemic Agents Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Oral Hypoglycemic Agents Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Oral Hypoglycemic Agents Market Share by Application (2017-2028)
    8.4 Asia-Pacific Oral Hypoglycemic Agents Market Size by Region
        8.4.1 Asia-Pacific Oral Hypoglycemic Agents Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Oral Hypoglycemic Agents Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Oral Hypoglycemic Agents Market Size (2017-2028)
    9.2 Latin America Oral Hypoglycemic Agents Market Size by Type
        9.2.1 Latin America Oral Hypoglycemic Agents Market Size by Type (2017-2022)
        9.2.2 Latin America Oral Hypoglycemic Agents Market Size by Type (2023-2028)
        9.2.3 Latin America Oral Hypoglycemic Agents Market Share by Type (2017-2028)
    9.3 Latin America Oral Hypoglycemic Agents Market Size by Application
        9.3.1 Latin America Oral Hypoglycemic Agents Market Size by Application (2017-2022)
        9.3.2 Latin America Oral Hypoglycemic Agents Market Size by Application (2023-2028)
        9.3.3 Latin America Oral Hypoglycemic Agents Market Share by Application (2017-2028)
    9.4 Latin America Oral Hypoglycemic Agents Market Size by Country
        9.4.1 Latin America Oral Hypoglycemic Agents Market Size by Country (2017-2022)
        9.4.2 Latin America Oral Hypoglycemic Agents Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Oral Hypoglycemic Agents Market Size (2017-2028)
    10.2 Middle East & Africa Oral Hypoglycemic Agents Market Size by Type
        10.2.1 Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Oral Hypoglycemic Agents Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Oral Hypoglycemic Agents Market Share by Type (2017-2028)
    10.3 Middle East & Africa Oral Hypoglycemic Agents Market Size by Application
        10.3.1 Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Oral Hypoglycemic Agents Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Oral Hypoglycemic Agents Market Share by Application (2017-2028)
    10.4 Middle East & Africa Oral Hypoglycemic Agents Market Size by Country
        10.4.1 Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Oral Hypoglycemic Agents Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Eli Lilly and Company
        11.1.1 Eli Lilly and Company Company Details
        11.1.2 Eli Lilly and Company Business Overview
        11.1.3 Eli Lilly and Company Oral Hypoglycemic Agents Introduction
        11.1.4 Eli Lilly and Company Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.1.5 Eli Lilly and Company Recent Developments
    11.2 Janssen Pharmaceuticals
        11.2.1 Janssen Pharmaceuticals Company Details
        11.2.2 Janssen Pharmaceuticals Business Overview
        11.2.3 Janssen Pharmaceuticals Oral Hypoglycemic Agents Introduction
        11.2.4 Janssen Pharmaceuticals Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.2.5 Janssen Pharmaceuticals Recent Developments
    11.3 Astellas Pharma Inc.
        11.3.1 Astellas Pharma Inc. Company Details
        11.3.2 Astellas Pharma Inc. Business Overview
        11.3.3 Astellas Pharma Inc. Oral Hypoglycemic Agents Introduction
        11.3.4 Astellas Pharma Inc. Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.3.5 Astellas Pharma Inc. Recent Developments
    11.4 AstraZeneca plc
        11.4.1 AstraZeneca plc Company Details
        11.4.2 AstraZeneca plc Business Overview
        11.4.3 AstraZeneca plc Oral Hypoglycemic Agents Introduction
        11.4.4 AstraZeneca plc Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.4.5 AstraZeneca plc Recent Developments
    11.5 Sanofi S.A.
        11.5.1 Sanofi S.A. Company Details
        11.5.2 Sanofi S.A. Business Overview
        11.5.3 Sanofi S.A. Oral Hypoglycemic Agents Introduction
        11.5.4 Sanofi S.A. Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.5.5 Sanofi S.A. Recent Developments
    11.6 Takeda
        11.6.1 Takeda Company Details
        11.6.2 Takeda Business Overview
        11.6.3 Takeda Oral Hypoglycemic Agents Introduction
        11.6.4 Takeda Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.6.5 Takeda Recent Developments
    11.7 Pfizer Inc
        11.7.1 Pfizer Inc Company Details
        11.7.2 Pfizer Inc Business Overview
        11.7.3 Pfizer Inc Oral Hypoglycemic Agents Introduction
        11.7.4 Pfizer Inc Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.7.5 Pfizer Inc Recent Developments
    11.8 Beohringer Ingelgeim
        11.8.1 Beohringer Ingelgeim Company Details
        11.8.2 Beohringer Ingelgeim Business Overview
        11.8.3 Beohringer Ingelgeim Oral Hypoglycemic Agents Introduction
        11.8.4 Beohringer Ingelgeim Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.8.5 Beohringer Ingelgeim Recent Developments
    11.9 Merk and Co.
        11.9.1 Merk and Co. Company Details
        11.9.2 Merk and Co. Business Overview
        11.9.3 Merk and Co. Oral Hypoglycemic Agents Introduction
        11.9.4 Merk and Co. Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.9.5 Merk and Co. Recent Developments
    11.10 Bristol Myers Squibb
        11.10.1 Bristol Myers Squibb Company Details
        11.10.2 Bristol Myers Squibb Business Overview
        11.10.3 Bristol Myers Squibb Oral Hypoglycemic Agents Introduction
        11.10.4 Bristol Myers Squibb Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.10.5 Bristol Myers Squibb Recent Developments
    11.11 Novartis International AG
        11.11.1 Novartis International AG Company Details
        11.11.2 Novartis International AG Business Overview
        11.11.3 Novartis International AG Oral Hypoglycemic Agents Introduction
        11.11.4 Novartis International AG Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.11.5 Novartis International AG Recent Developments
    11.12 Abbott Laboratories
        11.12.1 Abbott Laboratories Company Details
        11.12.2 Abbott Laboratories Business Overview
        11.12.3 Abbott Laboratories Oral Hypoglycemic Agents Introduction
        11.12.4 Abbott Laboratories Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.12.5 Abbott Laboratories Recent Developments
    11.13 Biocon Limited
        11.13.1 Biocon Limited Company Details
        11.13.2 Biocon Limited Business Overview
        11.13.3 Biocon Limited Oral Hypoglycemic Agents Introduction
        11.13.4 Biocon Limited Revenue in Oral Hypoglycemic Agents Business (2017-2022)
        11.13.5 Biocon Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Oral Hypoglycemic Agents Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Liquid
    Table 3. Key Players of Capsule
    Table 4. Key Players of Tablet
    Table 5. Global Oral Hypoglycemic Agents Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Oral Hypoglycemic Agents Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Oral Hypoglycemic Agents Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Oral Hypoglycemic Agents Market Share by Region (2017-2022)
    Table 9. Global Oral Hypoglycemic Agents Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Oral Hypoglycemic Agents Market Share by Region (2023-2028)
    Table 11. Oral Hypoglycemic Agents Market Trends
    Table 12. Oral Hypoglycemic Agents Market Drivers
    Table 13. Oral Hypoglycemic Agents Market Challenges
    Table 14. Oral Hypoglycemic Agents Market Restraints
    Table 15. Global Oral Hypoglycemic Agents Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Oral Hypoglycemic Agents Revenue Share by Players (2017-2022)
    Table 17. Global Top Oral Hypoglycemic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Hypoglycemic Agents as of 2021)
    Table 18. Ranking of Global Top Oral Hypoglycemic Agents Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Oral Hypoglycemic Agents Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Oral Hypoglycemic Agents Product Solution and Service
    Table 22. Date of Enter into Oral Hypoglycemic Agents Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Oral Hypoglycemic Agents Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Oral Hypoglycemic Agents Revenue Market Share by Type (2017-2022)
    Table 26. Global Oral Hypoglycemic Agents Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Oral Hypoglycemic Agents Revenue Market Share by Type (2023-2028)
    Table 28. Global Oral Hypoglycemic Agents Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Oral Hypoglycemic Agents Revenue Share by Application (2017-2022)
    Table 30. Global Oral Hypoglycemic Agents Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Oral Hypoglycemic Agents Revenue Share by Application (2023-2028)
    Table 32. North America Oral Hypoglycemic Agents Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Oral Hypoglycemic Agents Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Oral Hypoglycemic Agents Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Oral Hypoglycemic Agents Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Oral Hypoglycemic Agents Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Oral Hypoglycemic Agents Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Oral Hypoglycemic Agents Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Oral Hypoglycemic Agents Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Oral Hypoglycemic Agents Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Oral Hypoglycemic Agents Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Oral Hypoglycemic Agents Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Oral Hypoglycemic Agents Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Oral Hypoglycemic Agents Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Oral Hypoglycemic Agents Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Oral Hypoglycemic Agents Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Oral Hypoglycemic Agents Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Oral Hypoglycemic Agents Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Oral Hypoglycemic Agents Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Oral Hypoglycemic Agents Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Oral Hypoglycemic Agents Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Oral Hypoglycemic Agents Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Oral Hypoglycemic Agents Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Oral Hypoglycemic Agents Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Oral Hypoglycemic Agents Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Oral Hypoglycemic Agents Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Oral Hypoglycemic Agents Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Oral Hypoglycemic Agents Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Oral Hypoglycemic Agents Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Oral Hypoglycemic Agents Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Oral Hypoglycemic Agents Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Eli Lilly and Company Company Details
    Table 63. Eli Lilly and Company Business Overview
    Table 64. Eli Lilly and Company Oral Hypoglycemic Agents Product
    Table 65. Eli Lilly and Company Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 66. Eli Lilly and Company Recent Developments
    Table 67. Janssen Pharmaceuticals Company Details
    Table 68. Janssen Pharmaceuticals Business Overview
    Table 69. Janssen Pharmaceuticals Oral Hypoglycemic Agents Product
    Table 70. Janssen Pharmaceuticals Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 71. Janssen Pharmaceuticals Recent Developments
    Table 72. Astellas Pharma Inc. Company Details
    Table 73. Astellas Pharma Inc. Business Overview
    Table 74. Astellas Pharma Inc. Oral Hypoglycemic Agents Product
    Table 75. Astellas Pharma Inc. Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 76. Astellas Pharma Inc. Recent Developments
    Table 77. AstraZeneca plc Company Details
    Table 78. AstraZeneca plc Business Overview
    Table 79. AstraZeneca plc Oral Hypoglycemic Agents Product
    Table 80. AstraZeneca plc Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 81. AstraZeneca plc Recent Developments
    Table 82. Sanofi S.A. Company Details
    Table 83. Sanofi S.A. Business Overview
    Table 84. Sanofi S.A. Oral Hypoglycemic Agents Product
    Table 85. Sanofi S.A. Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 86. Sanofi S.A. Recent Developments
    Table 87. Takeda Company Details
    Table 88. Takeda Business Overview
    Table 89. Takeda Oral Hypoglycemic Agents Product
    Table 90. Takeda Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 91. Takeda Recent Developments
    Table 92. Pfizer Inc Company Details
    Table 93. Pfizer Inc Business Overview
    Table 94. Pfizer Inc Oral Hypoglycemic Agents Product
    Table 95. Pfizer Inc Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 96. Pfizer Inc Recent Developments
    Table 97. Beohringer Ingelgeim Company Details
    Table 98. Beohringer Ingelgeim Business Overview
    Table 99. Beohringer Ingelgeim Oral Hypoglycemic Agents Product
    Table 100. Beohringer Ingelgeim Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 101. Beohringer Ingelgeim Recent Developments
    Table 102. Merk and Co. Company Details
    Table 103. Merk and Co. Business Overview
    Table 104. Merk and Co. Oral Hypoglycemic Agents Product
    Table 105. Merk and Co. Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 106. Merk and Co. Recent Developments
    Table 107. Bristol Myers Squibb Company Details
    Table 108. Bristol Myers Squibb Business Overview
    Table 109. Bristol Myers Squibb Oral Hypoglycemic Agents Product
    Table 110. Bristol Myers Squibb Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 111. Bristol Myers Squibb Recent Developments
    Table 112. Novartis International AG Company Details
    Table 113. Novartis International AG Business Overview
    Table 114. Novartis International AG Oral Hypoglycemic Agents Product
    Table 115. Novartis International AG Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 116. Novartis International AG Recent Developments
    Table 117. Abbott Laboratories Company Details
    Table 118. Abbott Laboratories Business Overview
    Table 119. Abbott Laboratories Oral Hypoglycemic Agents Product
    Table 120. Abbott Laboratories Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 121. Abbott Laboratories Recent Developments
    Table 122. Biocon Limited Company Details
    Table 123. Biocon Limited Business Overview
    Table 124. Biocon Limited Oral Hypoglycemic Agents Product
    Table 125. Biocon Limited Revenue in Oral Hypoglycemic Agents Business (2017-2022) & (US$ Million)
    Table 126. Biocon Limited Recent Developments
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oral Hypoglycemic Agents Market Share by Type: 2021 VS 2028
    Figure 2. Liquid Features
    Figure 3. Capsule Features
    Figure 4. Tablet Features
    Figure 5. Global Oral Hypoglycemic Agents Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Pharmacies Case Studies
    Figure 7. Retail Pharmacies Case Studies
    Figure 8. Online Pharmacies Case Studies
    Figure 9. Oral Hypoglycemic Agents Report Years Considered
    Figure 10. Global Oral Hypoglycemic Agents Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Oral Hypoglycemic Agents Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Oral Hypoglycemic Agents Market Share by Region: 2021 VS 2028
    Figure 13. Global Oral Hypoglycemic Agents Market Share by Players in 2021
    Figure 14. Global Top Oral Hypoglycemic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Hypoglycemic Agents as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Oral Hypoglycemic Agents Revenue in 2021
    Figure 16. North America Oral Hypoglycemic Agents Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Oral Hypoglycemic Agents Market Size Market Share by Type (2017-2028)
    Figure 18. North America Oral Hypoglycemic Agents Market Size Market Share by Application (2017-2028)
    Figure 19. North America Oral Hypoglycemic Agents Market Size Share by Country (2017-2028)
    Figure 20. United States Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Oral Hypoglycemic Agents Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Oral Hypoglycemic Agents Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Oral Hypoglycemic Agents Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Oral Hypoglycemic Agents Market Size Share by Country (2017-2028)
    Figure 26. Germany Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Oral Hypoglycemic Agents Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Oral Hypoglycemic Agents Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Oral Hypoglycemic Agents Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Oral Hypoglycemic Agents Market Size Share by Region (2017-2028)
    Figure 36. China Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Oral Hypoglycemic Agents Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Oral Hypoglycemic Agents Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Oral Hypoglycemic Agents Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Oral Hypoglycemic Agents Market Size Share by Country (2017-2028)
    Figure 46. Mexico Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Oral Hypoglycemic Agents Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Oral Hypoglycemic Agents Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Oral Hypoglycemic Agents Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Oral Hypoglycemic Agents Market Size Share by Country (2017-2028)
    Figure 52. Turkey Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Oral Hypoglycemic Agents Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Eli Lilly and Company Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 56. Janssen Pharmaceuticals Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 57. Astellas Pharma Inc. Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 58. AstraZeneca plc Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 59. Sanofi S.A. Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 60. Takeda Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 61. Pfizer Inc Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 62. Beohringer Ingelgeim Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 63. Merk and Co. Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 64. Bristol Myers Squibb Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 65. Novartis International AG Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 66. Abbott Laboratories Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 67. Biocon Limited Revenue Growth Rate in Oral Hypoglycemic Agents Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed